English

PHARMAGENICS INC /DE/

EDGAR

Quarterly report (10-Q) · filed 1997-05-20

5 filing records in this dataset, filed from 1996-05-13 to 1997-05-20. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

74.8 thousand USD

1997-03-31 · USD

Exact inputs and evidence

Revenue: 74844 USD Source

Operating margin

-7,699.87%

1997-03-31 · %

Exact inputs and evidence

Operating Income: -5762892 USD Source
Revenue: 74844 USD Source

Operating cash flow

-1.76 million USD

1997-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -1763445 USD Source

Free cash flow

-1.77 million USD

1997-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -1763445 USD Source
Capital Expenditure: 9278 USD Source

Cash and cash equivalents: 360 thousand USD 1997-03-31 Source
Exact value

359982 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

995 thousand USD

1996-04-01 – 1997-03-31

Exact inputs and evidence

Revenue: 360649 USD · 1996-04-01 – 1996-06-30 Source
Revenue: 145600 USD · 1996-07-01 – 1996-09-30 Source
Revenue: 1418445 USD · 1996-01-01 – 1996-12-31 Source
Revenue: 1004719 USD · 1996-01-01 – 1996-09-30 Source
Revenue: 74844 USD · 1997-01-01 – 1997-03-31 Source

Net income

-9.63 million USD

1996-04-01 – 1997-03-31

Exact inputs and evidence

Net income: -1152396 USD · 1996-04-01 – 1996-06-30 Source
Net income: -1257337 USD · 1996-07-01 – 1996-09-30 Source
Net income: -4752633 USD · 1996-01-01 – 1996-12-31 Source
Net income: -3304944 USD · 1996-01-01 – 1996-09-30 Source
Net income: -5772249 USD · 1997-01-01 – 1997-03-31 Source

Operating cash flow

-5.14 million USD

1996-04-01 – 1997-03-31

Exact inputs and evidence

Operating cash flow: -2321536 USD · 1996-01-01 – 1996-06-30 Source
Operating cash flow: -1128317 USD · 1996-01-01 – 1996-03-31 Source
Operating cash flow: -3400458 USD · 1996-01-01 – 1996-09-30 Source
Operating cash flow: -2321536 USD · 1996-01-01 – 1996-06-30 Source
Operating cash flow: -4508742 USD · 1996-01-01 – 1996-12-31 Source
Operating cash flow: -3400458 USD · 1996-01-01 – 1996-09-30 Source
Operating cash flow: -1763445 USD · 1997-01-01 – 1997-03-31 Source

Capital expenditure

156 thousand USD

1996-04-01 – 1997-03-31

Exact inputs and evidence

Capital expenditure: 147722 USD · 1996-01-01 – 1996-06-30 Source
Capital expenditure: 8816 USD · 1996-01-01 – 1996-03-31 Source
Capital expenditure: 153864 USD · 1996-01-01 – 1996-09-30 Source
Capital expenditure: 147722 USD · 1996-01-01 – 1996-06-30 Source
Capital expenditure: 155352 USD · 1996-01-01 – 1996-12-31 Source
Capital expenditure: 153864 USD · 1996-01-01 – 1996-09-30 Source
Capital expenditure: 9278 USD · 1997-01-01 – 1997-03-31 Source

Free cash flow

-5.3 million USD

1996-04-01 – 1997-03-31

Exact inputs and evidence

Operating cash flow: -2321536 USD · 1996-01-01 – 1996-06-30 Source
Operating cash flow: -1128317 USD · 1996-01-01 – 1996-03-31 Source
Operating cash flow: -3400458 USD · 1996-01-01 – 1996-09-30 Source
Operating cash flow: -2321536 USD · 1996-01-01 – 1996-06-30 Source
Operating cash flow: -4508742 USD · 1996-01-01 – 1996-12-31 Source
Operating cash flow: -3400458 USD · 1996-01-01 – 1996-09-30 Source
Operating cash flow: -1763445 USD · 1997-01-01 – 1997-03-31 Source
Capital expenditure: 147722 USD · 1996-01-01 – 1996-06-30 Source
Capital expenditure: 8816 USD · 1996-01-01 – 1996-03-31 Source
Capital expenditure: 153864 USD · 1996-01-01 – 1996-09-30 Source
Capital expenditure: 147722 USD · 1996-01-01 – 1996-06-30 Source
Capital expenditure: 155352 USD · 1996-01-01 – 1996-12-31 Source
Capital expenditure: 153864 USD · 1996-01-01 – 1996-09-30 Source
Capital expenditure: 9278 USD · 1997-01-01 – 1997-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 1997-05-20.

Financial data available through: 1996-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 1996-12-31
Operating income: 3 of 11 periods available· newest 1996-12-31
Net income: 3 of 11 periods available· newest 1996-12-31
Operating cash flow: 3 of 11 periods available· newest 1996-12-31
Capital expenditure: 3 of 11 periods available· newest 1996-12-31
Total assets: 2 of 11 periods available· newest 1996-12-31
Total liabilities: 2 of 11 periods available· newest 1996-12-31
Current assets: 2 of 11 periods available· newest 1996-12-31
Current liabilities: 2 of 11 periods available· newest 1996-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 1996-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-51.4%

Prior period

USD 2.92 million

1995-01-01 – 1995-12-31
Current period

USD 1.42 million

1996-01-01 – 1996-12-31

Exact inputs and evidence

1418445 − 2920671 = -1502226 USD

2920671 USD · 1995-01-01 – 1995-12-31
Inspect prior input Prior source
1418445 USD · 1996-01-01 – 1996-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · PHARMAGENICS INC /DE/ · 1996-12-31 PHARMAGENICS INC /DE/ (edgar:887139) Year-over-year change in Revenue: -1502226 USD Concept: fundies:Revenue Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-05T02:44:53Z Snapshot: e664fe54f3e99f7274daf6687f4727fb4fad58a3e103babb76ffc3094a92db12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887139?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1418445 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3292 Input fundies:Revenue: 2920671 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3292
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 1.37 million

Prior period

−USD 3.38 million

1995-01-01 – 1995-12-31
Current period

−USD 4.75 million

1996-01-01 – 1996-12-31

Exact inputs and evidence

-4752633 − -3379547 = -1373086 USD

-3379547 USD · 1995-01-01 – 1995-12-31
Inspect prior input Prior source
-4752633 USD · 1996-01-01 – 1996-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · PHARMAGENICS INC /DE/ · 1996-12-31 PHARMAGENICS INC /DE/ (edgar:887139) Year-over-year change in Net income: -1373086 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-05T02:44:53Z Snapshot: e664fe54f3e99f7274daf6687f4727fb4fad58a3e103babb76ffc3094a92db12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887139?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -4752633 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3499 Input fundies:NetIncome: -3379547 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3499
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 2.85 million

Prior period

−USD 1.66 million

1995-01-01 – 1995-12-31
Current period

−USD 4.51 million

1996-01-01 – 1996-12-31

Exact inputs and evidence

-4508742 − -1660125 = -2848617 USD

-1660125 USD · 1995-01-01 – 1995-12-31
Inspect prior input Prior source
-4508742 USD · 1996-01-01 – 1996-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · PHARMAGENICS INC /DE/ · 1996-12-31 PHARMAGENICS INC /DE/ (edgar:887139) Year-over-year change in Operating cash flow: -2848617 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-05T02:44:53Z Snapshot: e664fe54f3e99f7274daf6687f4727fb4fad58a3e103babb76ffc3094a92db12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887139?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -4508742 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3515 Input fundies:OperatingCashFlow: -1660125 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3515
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+353.1%

Prior period

USD 34,290

1995-01-01 – 1995-12-31
Current period

USD 155,352

1996-01-01 – 1996-12-31

Exact inputs and evidence

155352 − 34290 = 121062 USD

34290 USD · 1995-01-01 – 1995-12-31
Inspect prior input Prior source
155352 USD · 1996-01-01 – 1996-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · PHARMAGENICS INC /DE/ · 1996-12-31 PHARMAGENICS INC /DE/ (edgar:887139) Year-over-year change in Capital expenditure: 121062 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-05T02:44:53Z Snapshot: e664fe54f3e99f7274daf6687f4727fb4fad58a3e103babb76ffc3094a92db12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887139?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 155352 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3520 Input fundies:CapitalExpenditure: 34290 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3520
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1996 1996-01-01 – 1996-12-31

Revenue USD 1.42 million 100% of revenue
Operating costs Derived USD 6.26 million 441% of revenue
Operating income −USD 4.84 million −341% of revenue
Tax, interest and other Derived −USD 83,925 −5.9% of revenue
Net income −USD 4.75 million −335% of revenue

Cash

Operating cash flow −USD 4.51 million −318% of revenue
Capital expenditure USD 155,352 11% of revenue
Free cash flow Derived −USD 4.66 million −329% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1994 Operating loss: operating costs were 400% of revenue.
1995 Operating loss: operating costs were 205% of revenue.
1996 Operating loss: operating costs were 441% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1994 1994-01-01 – 1994-12-31	1818209	7269041 Derived	-5450832	36984 Derived	-5487816	-3408748 Derived	Source 1994-01-01 – 1994-12-31: 1818209 USD Inspect Revenue Open source 1994-01-01 – 1994-12-31: -5450832 USD Inspect Operating Income Open source 1994-01-01 – 1994-12-31: -5487816 USD Inspect Net Income Open source 1994-01-01 – 1994-12-31: -3279722 USD Inspect Operating Cash Flow Open source 1994-01-01 – 1994-12-31: 129026 USD Inspect Capital Expenditure Open source
1995 1995-01-01 – 1995-12-31	2920671	5996366 Derived	-3075695	303852 Derived	-3379547	-1694415 Derived	Source 1995-01-01 – 1995-12-31: 2920671 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -3075695 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -3379547 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -1660125 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 34290 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	1418445	6255003 Derived	-4836558	-83925 Derived	-4752633	-4664094 Derived	Source 1996-01-01 – 1996-12-31: 1418445 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -4836558 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -4752633 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -4508742 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 155352 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.4M 1996

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Revenue	1818209	Revenue: 1818209 Open source
19951995-12-31	Revenue	2920671	Revenue: 2920671 Open source
19961996-12-31	Revenue	1418445	Revenue: 1418445 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-51.4% 1996

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Year over year	No prior comparable period	Revenue: 1818209 Open source
19951995-12-31	Year over year	60.6%	Revenue: 2920671 Open source Revenue: 1818209 Open source
19961996-12-31	Year over year	-51.4%	Revenue: 1418445 Open source Revenue: 2920671 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -341% 1996

Net margin -335.1% 1996

Free cash flow margin -328.8% 1996

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Operating margin	-299.8%	Operating Income: -5450832 Open source Revenue: 1818209 Open source
19951995-12-31	Operating margin	-105.3%	Operating Income: -3075695 Open source Revenue: 2920671 Open source
19961996-12-31	Operating margin	-341%	Operating Income: -4836558 Open source Revenue: 1418445 Open source
19941994-12-31	Net margin	-301.8%	Net Income: -5487816 Open source Revenue: 1818209 Open source
19951995-12-31	Net margin	-115.7%	Net Income: -3379547 Open source Revenue: 2920671 Open source
19961996-12-31	Net margin	-335.1%	Net Income: -4752633 Open source Revenue: 1418445 Open source
19941994-12-31	Free cash flow margin	-187.5%	Revenue: 1818209 Open source Operating Cash Flow: -3279722 Open source Capital Expenditure: 129026 Open source
19951995-12-31	Free cash flow margin	-58%	Revenue: 2920671 Open source Operating Cash Flow: -1660125 Open source Capital Expenditure: 34290 Open source
19961996-12-31	Free cash flow margin	-328.8%	Revenue: 1418445 Open source Operating Cash Flow: -4508742 Open source Capital Expenditure: 155352 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -4.5M 1996

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Operating cash flow	-3279722	Operating Cash Flow: -3279722 Open source
19951995-12-31	Operating cash flow	-1660125	Operating Cash Flow: -1660125 Open source
19961996-12-31	Operating cash flow	-4508742	Operating Cash Flow: -4508742 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -4.7M 1996

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Free cash flow	-3408748	Operating Cash Flow: -3279722 Open source Capital Expenditure: 129026 Open source
19951995-12-31	Free cash flow	-1694415	Operating Cash Flow: -1660125 Open source Capital Expenditure: 34290 Open source
19961996-12-31	Free cash flow	-4664094	Operating Cash Flow: -4508742 Open source Capital Expenditure: 155352 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

136.1% 1996

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Liabilities / assets	Not reported	No source recorded
19951995-12-31	Liabilities / assets	86.9%	Total Liabilities: 2342066 Open source Total Assets: 2693625 Open source
19961996-12-31	Liabilities / assets	136.1%	Total Liabilities: 2087466 Open source Total Assets: 1533327 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.34× 1996

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Current assets / current liabilities	Not reported	No source recorded
19951995-12-31	Current assets / current liabilities	0.72×	Current Assets: 1662152 Open source Current Liabilities: 2302786 Open source
19961996-12-31	Current assets / current liabilities	0.34×	Current Assets: 710264 Open source Current Liabilities: 2062289 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1994-01-01 – 1994-12-31	−USD 5.49 million Exact value Exact value: -5487816 USD 1994-01-01 – 1994-12-31: -5487816 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMAGENICS INC /DE/ · 1994-12-31 PHARMAGENICS INC /DE/ (edgar:887139) Net Income: -5487816 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-05T02:44:53Z Snapshot: e664fe54f3e99f7274daf6687f4727fb4fad58a3e103babb76ffc3094a92db12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887139/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5487816 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3499 The citation records this snapshot. The page link may show a newer release later.	−USD 3.28 million Exact value Exact value: -3279722 USD 1994-01-01 – 1994-12-31: -3279722 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMAGENICS INC /DE/ · 1994-12-31 PHARMAGENICS INC /DE/ (edgar:887139) Operating Cash Flow: -3279722 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-05T02:44:53Z Snapshot: e664fe54f3e99f7274daf6687f4727fb4fad58a3e103babb76ffc3094a92db12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887139/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3279722 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3515 The citation records this snapshot. The page link may show a newer release later.	USD 129,026 Exact value Exact value: 129026 USD 1994-01-01 – 1994-12-31: 129026 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMAGENICS INC /DE/ · 1994-12-31 PHARMAGENICS INC /DE/ (edgar:887139) Capital Expenditure: 129026 USD Concept: fundies:CapitalExpenditure Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-05T02:44:53Z Snapshot: e664fe54f3e99f7274daf6687f4727fb4fad58a3e103babb76ffc3094a92db12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887139/explain?concept=fundies%3ACapitalExpenditure&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 129026 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3520 The citation records this snapshot. The page link may show a newer release later.	−USD 3.41 million Calculation and evidence -3279722 − 129026 USD Exact free cash flow: -3408748 USD 1994-01-01 – 1994-12-31: -3279722 USD · Inspect Operating Cash Flow · Source 1994-01-01 – 1994-12-31: 129026 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMAGENICS INC /DE/ · 1994-12-31 PHARMAGENICS INC /DE/ (edgar:887139) Free cash flow: -3408748 USD Concept: free-cash-flow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-05T02:44:53Z Snapshot: e664fe54f3e99f7274daf6687f4727fb4fad58a3e103babb76ffc3094a92db12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887139?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3279722 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3515 Input fundies:CapitalExpenditure: 129026 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3520 The citation records this snapshot. The page link may show a newer release later.
1995 1995-01-01 – 1995-12-31	−USD 3.38 million Exact value Exact value: -3379547 USD 1995-01-01 – 1995-12-31: -3379547 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMAGENICS INC /DE/ · 1995-12-31 PHARMAGENICS INC /DE/ (edgar:887139) Net Income: -3379547 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-05T02:44:53Z Snapshot: e664fe54f3e99f7274daf6687f4727fb4fad58a3e103babb76ffc3094a92db12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887139/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3379547 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3499 The citation records this snapshot. The page link may show a newer release later.	−USD 1.66 million Exact value Exact value: -1660125 USD 1995-01-01 – 1995-12-31: -1660125 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMAGENICS INC /DE/ · 1995-12-31 PHARMAGENICS INC /DE/ (edgar:887139) Operating Cash Flow: -1660125 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-05T02:44:53Z Snapshot: e664fe54f3e99f7274daf6687f4727fb4fad58a3e103babb76ffc3094a92db12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887139/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1660125 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3515 The citation records this snapshot. The page link may show a newer release later.	USD 34,290 Exact value Exact value: 34290 USD 1995-01-01 – 1995-12-31: 34290 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMAGENICS INC /DE/ · 1995-12-31 PHARMAGENICS INC /DE/ (edgar:887139) Capital Expenditure: 34290 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-05T02:44:53Z Snapshot: e664fe54f3e99f7274daf6687f4727fb4fad58a3e103babb76ffc3094a92db12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887139/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 34290 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3520 The citation records this snapshot. The page link may show a newer release later.	−USD 1.69 million Calculation and evidence -1660125 − 34290 USD Exact free cash flow: -1694415 USD 1995-01-01 – 1995-12-31: -1660125 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 34290 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMAGENICS INC /DE/ · 1995-12-31 PHARMAGENICS INC /DE/ (edgar:887139) Free cash flow: -1694415 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-05T02:44:53Z Snapshot: e664fe54f3e99f7274daf6687f4727fb4fad58a3e103babb76ffc3094a92db12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887139?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1660125 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3515 Input fundies:CapitalExpenditure: 34290 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3520 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 4.75 million Exact value Exact value: -4752633 USD 1996-01-01 – 1996-12-31: -4752633 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMAGENICS INC /DE/ · 1996-12-31 PHARMAGENICS INC /DE/ (edgar:887139) Net Income: -4752633 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-05T02:44:53Z Snapshot: e664fe54f3e99f7274daf6687f4727fb4fad58a3e103babb76ffc3094a92db12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887139/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4752633 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3499 The citation records this snapshot. The page link may show a newer release later.	−USD 4.51 million Exact value Exact value: -4508742 USD 1996-01-01 – 1996-12-31: -4508742 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMAGENICS INC /DE/ · 1996-12-31 PHARMAGENICS INC /DE/ (edgar:887139) Operating Cash Flow: -4508742 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-05T02:44:53Z Snapshot: e664fe54f3e99f7274daf6687f4727fb4fad58a3e103babb76ffc3094a92db12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887139/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4508742 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3515 The citation records this snapshot. The page link may show a newer release later.	USD 155,352 Exact value Exact value: 155352 USD 1996-01-01 – 1996-12-31: 155352 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMAGENICS INC /DE/ · 1996-12-31 PHARMAGENICS INC /DE/ (edgar:887139) Capital Expenditure: 155352 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-05T02:44:53Z Snapshot: e664fe54f3e99f7274daf6687f4727fb4fad58a3e103babb76ffc3094a92db12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887139/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 155352 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3520 The citation records this snapshot. The page link may show a newer release later.	−USD 4.66 million Calculation and evidence -4508742 − 155352 USD Exact free cash flow: -4664094 USD 1996-01-01 – 1996-12-31: -4508742 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 155352 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMAGENICS INC /DE/ · 1996-12-31 PHARMAGENICS INC /DE/ (edgar:887139) Free cash flow: -4664094 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-05T02:44:53Z Snapshot: e664fe54f3e99f7274daf6687f4727fb4fad58a3e103babb76ffc3094a92db12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887139?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4508742 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3515 Input fundies:CapitalExpenditure: 155352 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887139/0000912057-97-012258.txt#3520 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

5 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-05. Source filing dates and reporting periods are shown separately.

Identifiers: 0000887139, 887139, edgar:887139

PHARMAGENICS INC /DE/

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

1996 1996-01-01 – 1996-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation